Drug Pipeline

FOLFOX regimen Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
8
Active Studies
3
Recruiting
1
Phase 3
5
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
5
Phase 1/2
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07340567 Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal… Colorectal Cancer Not Yet Recruiting
Phase 2
NCT06475352 Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking… Digestive Cancer Recruiting
NCT06846346 Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic… Metastatic Esophageal Adenocarcinoma Recruiting
NCT06529718 Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients Biliary Tract Cancer Recruiting
NCT03483038 A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU… Pancreatic Adenocarcinoma Active, Not Recruiting
NCT03548961 Organ Preservation in Early Rectal Cancer Patients Rectal Cancer Active, Not Recruiting
Phase 1/2
NCT07522411 Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct… Hepatocellular Carcinoma Not Yet Recruiting
Early Phase 1
NCT05108428 Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma Rectal Adenocarcinoma Active, Not Recruiting
Sponsors Running FOLFOX regimen Trials
Disease Areas
Get alerts when FOLFOX regimen trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free